Skip to content

RNAV8 BIO

24 viewers · 30d

Total raised

$2.0M

1 filing since 2022 · latest Options filed

Cumulative raised
LAST ROUND
Options · $2.0M
ROUNDS
1
INVESTORS
42
FOUNDED
2022
HQ
Laguna Niguel, CA
SECTOR
Biotech
EMPLOYEES
N/A
30D VIEWERS
24

AI overview

Updated

RNAV8 Bio, Inc. is an innovative biotechnology company dedicated to enhancing the efficacy of mRNA therapeutics. By harnessing advanced technologies like machine learning and artificial intelligence, RNAV8 aims to revolutionize the field of mRNA-based drug development for a wide array of diseases.

What sets it apart

RNAV8 stands out due to its unique integration of rational design with cutting-edge machine learning techniques, enhancing mRNA expression for more effective therapies.

Funding history

1 round
OptionsMay 9, 2022
Form D/A
+$2.0M$2.0M total

Latest SEC filings

via EDGAR · CIK 0001960745
Form D/A · May 9, 2022View on EDGAR

Products

1 tracked

mRNA Engineering and Design Platform

mRNA Therapeutics

The mRNA engineering and design platform developed by RNAV8 utilizes machine learning and artificial intelligence to optimize mRNA functions. This platform is designed to improve the expression levels of mRNA, thus enhancing the potency and specificity of mRNA-based therapeutics.

  • Integration of rational design techniques
  • Use of advanced machine learning algorithms
  • Capability to tailor mRNA functions for various applications
  • Enhanced mRNA expression compared to conventional approaches

Links

WebsiteSEC EDGAR filings